Cascadia Capital, an investment bank serving middle market clients globally, is pleased to announce it acted as the exclusive financial advisor to Tegria, an innovative company launched by Providence to provide next-generation technologies and services to the healthcare sector, in completing a major investment in Cloud21, a digital health consultancy based in the UK.
The investment from Tegria will allow the companies to combine Cloud21’s deep and longstanding experience of working with the NHS, with Tegria’s extensive international, end-to-end digital strategy and support services across healthcare.
Cloud21 will leverage Tegria’s global team of more than 3,500 clinicians, technologists, scientists, and strategists, to support healthcare systems and organizations, as they plan to implement government’s latest digital priorities and targets, and improve patient experiences and outcomes through technology.
Together the two organizations, who both focus solely on healthcare infrastructure, have unmatched experience in strategic transformation, enablement, and deployment, as well as proven credibility in the implementation and optimization of every single major EPR system.
“This investment is enabling Cloud21 to provide a unique offering to the health and social care sector and helping providers level-up or scale-up their digital abilities at local, regional, and national levels in the UK,” said Dr. Tony Corkett, CEO of Cloud21. “For technology to deliver benefits and enable staff to provide care effectively, we need to match any technology investment with equal investments in implementation and change management – taking our people on the journey and making the new processes work in the real world. Working with Tegria enhances our capabilities to deliver this at scale, throughout the entire digital journey.”
The companies have already started working together to help healthcare organizations accelerate their digital maturity, and discussions with healthcare leaders across the UK are at an advanced stage.
Tegria draws on and shares the lessons learned from working with 500+ healthcare organizations across the globe, to help them tackle the three cornerstones of any successful EPR program: the people, the processes, and the technology. Tegria’s founder, Providence, is a leading not-for-profit integrated care organization, and one of the largest health systems in the US, providing Tegria with unique insights on large scale digital transformation.
“As the NHS moves towards establishing integrated care boards and places and addresses the operational and cultural challenges of digital transformation, our end-to-end experience means we are uniquely placed to share decades of learning around optimizing digital and data,” added Justin Jozwik, Managing Director of Tegria.
“This, combined with Cloud21’s strong footprint as a trusted partner to the NHS and unmatched understanding of the varying levels of need across the sector, gives us an unprecedented opportunity to make meaningful change at pace and scale.”
This is the ninth transactions that Cascadia has supported for Tegria and Providence, having previously provided buy-side advisory services for Tegria and Providence acquisitions, including KenSci, Colburn Hill, Cumberland, Acclara Solutions, MediRevv, Bluetree and Navin, Haffty & Associates.
“Tegria’s international expansion into Europe is a major milestone for the organization,” said Kevin Cable, Co-Founder and Managing Director at Cascadia. “Our firm is proud to represent Tegria and Providence through this growth journey in creating a better healthcare infrastructure on a global scale.”
For more information about this transaction please contact:
Other senior members of the Cascadia Healthcare team include:
Senior Vice President